# Submucosal Intravesical Injection of Platelet-rich Plasma in the Treatment of Painful Bladder Syndrome

> **NCT06209008** · PHASE3 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 30 (actual)

## Conditions studied

- Painful Bladder Syndrome (PBS)
- Interstitial Cystitis

## Interventions

- **DRUG:** Intravesical injection of Platlet Rich Plasma (PRP)

## Key facts

- **NCT ID:** NCT06209008
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-01
- **Primary completion:** 2023-04-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2024-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06209008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06209008, "Submucosal Intravesical Injection of Platelet-rich Plasma in the Treatment of Painful Bladder Syndrome". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06209008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*